Thus, it is essential to delineate CRC-specific molecular networks through which rafts regulate immune escape, such as PD-L1 raft enrichment and immune cell dysfunction, to facilitate precise target identification and therapeutic development. This evidence concerns the gene CD274 and colorectal carcinoma.